TOMOE ENGINEERING CO.,LTD.(TOMOE KOGYO CO.,LTD.) FY2026 Q2 Earnings Report

Quick View

Executive Summary

The key takeaway from the current period was that the Company maintained its profit margins and secured earnings growth despite a decline in revenue. Revenue was ¥308.5B, down -1.5% year on year, while Operating Income declined only slightly to ¥37.0B, down -0.2%. Ordinary Income increased to ¥37.9B, up +1.8%, and Net Income rose to ¥27.9B, up +8.9%. The decline in revenue from the sale of chemical industrial products was offset by cost management, while extraordinary gains, including a ¥0.5B gain on the sale of investment securities, also boosted Net Income.

Factors Affecting Results

【Revenue】Consolidated Revenue was ¥308.5B, down 1.5% year on year. The main factor was a decline in Revenue from the Chemical Industrial Products Sales Business to ¥220.1B, down -2.1%. This business accounted for 71.3% of total Company Revenue. The Machinery Manufacturing and Sales Business remained nearly flat at ¥88.4B, up +0.0%, supporting consolidated Revenue.

【Profit and Loss】Operating Income was ¥37.0B, down -0.2%, essentially in line with the previous year, while the Operating Income Margin improved slightly to 12.0% from 11.9% in the same period of the previous year. Ordinary Income increased to ¥37.9B, up +1.8%, due to a positive contribution from non-operating income. Net Income rose to ¥27.9B, up +8.9%; however, Profit Before Tax of ¥41.4B included ¥3.5B in extraordinary gains, including a ¥0.5B gain on the sale of investment securities. Accordingly, the increase in Net Income included temporary factors that should be noted. Overall, the results represent declining revenue but growing earnings.

Segment Analysis

The core Machinery Manufacturing and Sales Business generated Operating Income of ¥18.7B, accounting for 50.6% of total Company Operating Income. Its segment profit margin of 21.2% was significantly above the consolidated profit margin of 12.0%. Revenue was ¥88.4B and remained nearly flat, while segment profit declined slightly by 0.7% year on year. The Chemical Industrial Products Sales Business contracted to Revenue of ¥220.1B, down -2.1%, but segment profit increased slightly to ¥18.3B, up +0.2%, resulting in a profit margin of 8.3%. The two businesses generated comparable levels of profit, with the highly profitable machinery business supporting profit margins and the chemical business supporting revenue scale.

Key Financial Metrics

【Profitability】The Operating Income Margin was 12.0% and the Net Profit Margin was 9.1%, both improving year on year. ROE on an annualized basis was 6.4%, decomposed into a Net Profit Margin of 9.1%, Total Asset Turnover of 0.54x, and Financial Leverage of 1.30x. The low Total Asset Turnover remains a constraint on capital efficiency.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥10.3B, representing only 0.37x Net Income of ¥27.9B. The increase of ¥14.8B in trade receivables was the primary factor delaying the conversion of earnings into cash.【Investment Efficiency】Capital expenditures of ¥4.2B were 2.7x depreciation and amortization expense of ¥1.6B, indicating that the Company continues to invest beyond maintenance requirements.【Financial Soundness】The Equity Ratio was a robust 76.9%. Liquidity was sufficient, with current assets of ¥413.5B compared with current liabilities of ¥118.5B.

Cash Flow Analysis

Operating Cash Flow (OCF) was ¥10.3B, a significant improvement from -¥11.8B in the same period of the previous year, although cash conversion remained delayed relative to Net Income of ¥27.9B. The ¥14.8B increase in trade receivables was the primary cash outflow factor, partially offset by a ¥7.5B decrease in inventories. Investing Cash Flow was -¥4.6B, mainly reflecting ¥4.2B in capital expenditures. Financing Cash Flow was -¥19.8B, with share repurchases of ¥9.0B and dividend payments representing the primary outflows. As a result, Free Cash Flow (OCF + Investing Cash Flow) remained positive at ¥5.7B; however, cash outflows from financing activities exceeded this amount, resulting in a decline in cash and cash equivalents from the end of the previous fiscal year.

Earnings Quality

Profit Before Tax was ¥41.4B compared with Ordinary Income of ¥37.9B. The primary reason for the 9.0% divergence was ¥3.5B in extraordinary gains, including a ¥0.5B gain on the sale of investment securities. Non-operating income was ¥1.0B, equivalent to only 0.3% of Revenue, and mainly comprised ¥0.3B in dividend income, indicating a low degree of dependence on non-operating income. OCF was only 0.37x Net Income, and deterioration in working capital, primarily due to the increase in trade receivables, created a divergence between accounting earnings and actual cash flow. Since the 8.9% year-on-year increase in Net Income included a contribution from extraordinary gains, recurring earning power should be assessed more cautiously based on the +1.8% increase in Ordinary Income.

Earnings Forecast and Guidance

The Full-Year plan remains unchanged at Revenue of ¥629.0B, up +6.0% year on year; Operating Income of ¥59.0B, up +10.2%; and Ordinary Income of ¥60.0B, up +11.1%. The first-half progress rate was 49.0% for Revenue, a standard level, while progress rates of 62.8% for Operating Income and 63.2% for Ordinary Income were more than 10 percentage points above the standard 50%. In addition to maintaining profitability in the first half, the recognition of extraordinary gains contributed to the advanced earnings progress. To achieve the Full-Year plan, the Company needs to secure an Operating Income Margin equivalent to 6.8% in the second half, or ¥21.97B, which is a more conservative assumption than the first-half result of 12.0%. Achieving the Full-Year Revenue plan requires second-half Revenue of ¥320.5B, making a recovery in second-half Revenue the key focus.

Shareholder Returns

The Q2 dividend was ¥36.00 per share, resulting in a Payout Ratio of approximately 38.6% against interim Net Income of ¥27.9B. The Full-Year dividend forecast is ¥76.00, representing an increase of ¥15.67 from the previous fiscal year's annual dividend of ¥60.33 after considering the stock split. The forecast Payout Ratio against the Full-Year Net Income plan of ¥44.0B is approximately 50.9%. Including ¥9.0B in share repurchases, the first-half Total Return Ratio was approximately 70.1% of Net Income, which should be distinguished from the dividend-only payout ratio. Although the combined amount of dividends and share repurchases exceeded first-half OCF of ¥10.3B, concerns regarding short-term payment capacity are limited given cash and deposits of ¥121.8B and the high Equity Ratio of 76.9%.

Risk Factors

1. Delay in cash conversion: OCF/Net Income remained at 0.37x, primarily due to the ¥14.8B increase in trade receivables. If earnings growth continues not to convert into cash flow, the Company's capacity to fund investments and shareholder returns through internally generated funds may be constrained.

2. Demand trends in the Chemical Industrial Products Sales Business: Revenue from this business declined 2.1% year on year to ¥220.1B. Demand for chemicals, raw material and energy prices, and the success or failure of passing through costs will determine the recovery of consolidated Revenue.

3. Quality of Net Income: The 8.9% year-on-year increase in Net Income included a contribution from ¥3.5B in extraordinary gains, including a ¥0.5B gain on the sale of investment securities. The impact of non-recurring factors was therefore significant compared with the +1.8% growth rate based on Ordinary Income.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company's profitability exceeds the industry median, with both its Operating Income Margin and Net Profit Margin at favorable levels.

Growth and Capital Efficiency

The Revenue Growth Rate was significantly below the industry median, placing the Company behind its industry peers in top-line growth.

Source: Compiled by the Company

Key Takeaways from the Results

1. The Company maintained an Operating Income Margin of 12.0% (11.9% in the same period of the previous year) despite declining Revenue, demonstrating earnings resilience. The core Machinery Manufacturing and Sales Business accounted for 50.6% of Operating Income compared with a 28.7% share of Revenue, and its 21.2% profit margin made it an important driver of consolidated earnings.

2. The first-half progress rate against the Full-Year Operating Income plan was 62.8%, above the standard 50%. However, given that the figure included net extraordinary gains of ¥3.5B, the Company's recurring earning power is more accurately assessed based on the +1.8% growth rate in Ordinary Income.

3. OCF/Net Income of 0.37x and the ¥14.8B increase in trade receivables signal a divergence between accounting earnings and cash generation. While the Company's substantial equity base of 76.9% and ample cash of ¥121.8B provide support, the status of receivables collection in the second half will be an important point for monitoring its financial condition.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,501–¥1,587 at Cost of Equity ±1%, and ¥1,542–¥1,545 at ω±0.1.

Notes:

• Because the progress of Net Income against the Full-Year forecast (63%) exceeds the standard level (50%), Forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of plan tend to outperform their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net assets as of the quarter-end have been used (there is a timing gap relative to the Full-Year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest Rate Reference Month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data. It does not constitute a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 performance was resilient at the operating level despite modest sales contraction, while reported net income benefited materially from extraordinary gains. Revenue declined 1.5% YoY to ¥30.85bn, but operating income was essentially stable at ¥3.70bn, down only 0.2% YoY. The operating margin improved 16bp YoY to 12.0%, remaining within the good 8-15% profitability range. Gross profit increased 0.4% to ¥8.65bn despite the revenue decline. Accordingly, gross margin expanded by approximately 100bp YoY to 28.0%, indicating improved sales mix and/or procurement discipline. SG&A expense increased 4.0% YoY to ¥4.95bn, outpacing revenue and absorbing most of the gross-profit improvement. Ordinary income rose 1.8% to ¥3.79bn, supported by an improvement in the non-operating balance. Net income rose 8.9% to ¥2.79bn, exceeding operating and ordinary-income trends. However, pre-tax profit included ¥3.50bn of extraordinary income, principally a ¥0.54bn gain on sales of investment securities alongside other extraordinary gains. The resulting net extraordinary contribution of ¥3.43bn was equivalent to 12.3% of Q2 net income, so reported bottom-line growth is not fully reflective of recurring earnings momentum. Operating cash flow turned positive at ¥1.03bn from an outflow of ¥1.18bn a year earlier, but remained well below net income. OCF/net income of 0.37x and OCF/EBITDA of 0.27x indicate that earnings conversion into cash was weak during the first half. The principal cash-flow drag was a ¥1.49bn increase in trade receivables, compounded by a ¥0.75bn inventory-related outflow and a ¥0.83bn reduction in bonus provisions. Financial resilience remains strong, with a 348.9% current ratio, a 76.9% equity ratio, and a conservative 0.30x debt-to-equity ratio. Free cash flow was positive at ¥0.57bn after ¥0.42bn of capital expenditure, though it did not fully cover the interim dividend cash requirement. The full-year operating-income forecast of ¥5.90bn implies a 62.8% Q2 progress rate, 12.8 percentage points above the standard 50% first-half pace, suggesting an expectation for a lower second-half earnings run rate or management conservatism. The core machinery manufacturing and sales business maintained high profitability, while the chemical industrial-products sales segment protected margins despite lower revenue. The near-term investment focus is therefore on receivable collection, working-capital normalization, the durability of gross-margin improvement, and conversion of the strong first-half forecast progress into sustainable full-year cash generation.

Profitability Analysis

Annualized DuPont ROE was 12.8%, comprising a 9.1% net profit margin, 1.083x asset turnover, and 1.30x financial leverage. This is a good ROE outcome under the stated benchmark, achieved primarily through healthy margins and asset utilization rather than aggressive balance-sheet leverage. The financial-leverage component is conservative, consistent with the 76.9% equity ratio and low debt-to-equity ratio, so the return profile is not dependent on financial risk-taking. The 12.0% EBIT margin is also solid for a mixed manufacturing and chemical-products sales structure. Gross margin expanded about 100bp YoY to 28.0%, while operating margin increased about 16bp because SG&A rose 4.0% YoY against a 1.5% sales decline. This SG&A/revenue divergence is the main pressure on operating leverage and should be monitored if sales do not return to growth. The machinery manufacturing and sales segment is the core business by segment profit contribution, generating ¥1.87bn of segment profit, or 50.6% of total segment operating income, on revenue of ¥8.84bn. Its revenue was effectively flat YoY, while segment profit declined 0.7% YoY and its segment margin eased 15bp to 21.2%; the business nonetheless remains the group’s highest-margin earnings engine. Chemical industrial-products sales generated revenue of ¥22.01bn, down 2.1% YoY, and segment profit of ¥1.83bn, up 0.2% YoY. Its segment margin improved 19bp to 8.3%, cushioning the effect of lower sales. Net margin was 9.1%, but its apparent strength incorporates the extraordinary-income contribution; the ordinary-income margin was 12.3% before extraordinary items. The tax burden was 0.675, corresponding to a 32.5% effective tax rate, while an interest burden above 1.0x reflects net non-operating income rather than financing stress.

Growth Assessment

Top-line momentum was modestly negative in Q2, with group revenue down 1.5% YoY, driven by a 2.1% decline in chemical industrial-products sales. Machinery manufacturing and sales revenue was stable at ¥8.84bn, providing a dependable base but not yet a source of material growth. Margin improvement in both segments, particularly in the chemical-products segment, demonstrates some pricing, mix, or cost-management resilience. The full-year forecast calls for revenue of ¥62.90bn, up 6.0% YoY, operating income of ¥5.90bn, up 10.2%, and ordinary income of ¥6.00bn, up 11.1%. Q2 revenue progress is 49.0% of the annual forecast, broadly in line with the standard 50% first-half progress rate. Operating-income progress is 62.8%, ordinary-income progress is 63.2%, and net-income progress is 63.5% versus the ¥4.40bn full-year target; each profit measure is more than 10 percentage points ahead of the standard pace. This profile implies that the second half is forecast to be less profitable than the first half, or that management has retained a prudent guidance stance. Since the first-half net-income result contains substantial extraordinary income, the elevated net-income progress rate should not be extrapolated as recurring earnings growth. Revenue recovery in chemical industrial-products sales and containment of SG&A growth will be central to achieving the forecasted full-year operating-income increase. CapEx of ¥0.42bn was 2.68x depreciation, signalling investment above replacement levels, although capital expenditure represented a restrained 1.3% of first-half revenue.

Financial Health

The balance sheet is highly liquid and conservatively capitalized. Current assets of ¥41.35bn cover current liabilities of ¥11.85bn by 3.49x, and the 2.96x quick ratio shows that liquidity is strong even excluding inventories. Working capital was ¥29.50bn, equivalent to substantial internal capacity to fund operations and shareholder returns. Cash and deposits were ¥12.18bn, exceeding trade payables of ¥5.01bn and providing a meaningful buffer against working-capital volatility. Total liabilities were only ¥13.14bn against equity of ¥43.82bn, producing a 76.9% equity ratio and 0.30x debt-to-equity ratio. There is no current-ratio warning or leverage warning: the current ratio is comfortably above 1.0x and D/E is well below 2.0x. Current liabilities are well covered by current assets, limiting maturity-mismatch risk. Contract liabilities of ¥1.07bn provide partial operating funding and may support revenue visibility as performance obligations are fulfilled. Deferred tax liabilities were ¥1.18bn, largely consistent with the group’s asset and investment base. Treasury stock increased from ¥0.03bn to ¥9.03bn, reflecting the ¥8.99bn share repurchase during the period. The buyback reduces cash and reported equity but is readily absorbable given the balance sheet’s substantial liquidity and capitalization. Intangible assets rose ¥0.98bn YoY to ¥1.73bn, including ¥1.12bn of intangible-asset purchases during the period. At only 0.3% of total assets, the intangible-asset base is immaterial to overall asset quality and does not create a meaningful amortization or impairment concentration.

Notable B/S Changes

Treasury stock: increased by ¥9.00bn from ¥0.03bn to ¥9.03bn, principally reflecting ¥8.99bn of share repurchases; the transaction is material to capital allocation and reduced period-end cash, but remains manageable given ¥12.18bn of cash and deposits and a 76.9% equity ratio. Intangible assets: increased by ¥0.98bn (+130.7%) to ¥1.73bn, consistent with ¥1.12bn of intangible-asset purchases; at 0.3% of total assets, the balance remains immaterial to group asset quality.

Cash Flow Quality

Cash-flow quality is the principal financial issue in FY2026 Q2. Operating cash flow was ¥1.03bn, equivalent to only 0.37x of ¥2.79bn net income and therefore below the 0.8x quality threshold. Cash conversion was also low at 0.27x of EBITDA, well below the 0.7x alert threshold. The shortfall was driven principally by a ¥1.49bn increase in trade receivables, a ¥0.75bn inventory-related cash outflow, and a ¥0.83bn reduction in bonus provisions. These movements indicate that a sizeable share of first-half reported earnings remains tied up in working capital rather than realized in cash. Annualized DSO was 84 days, exceeding the 60-day warning level and identifying collection efficiency as the most important operating working-capital metric to monitor. The annualized cash conversion cycle was 123 days, above the 120-day warning threshold, increasing sensitivity of operating cash flow to sales timing and customer payment behavior. The accruals ratio was nevertheless moderate at 3.1%, below the 5% high-quality benchmark, which tempers concern that the earnings base is broadly accrual-driven. Free cash flow was positive at ¥0.57bn after capital expenditure of ¥0.42bn, an improvement in underlying funding capacity compared with the prior-year operating cash outflow. CapEx/depreciation of 2.68x indicates investment spending is running above depreciation and supports asset renewal or growth initiatives. However, sustained dividend payments and buybacks require better operating cash conversion than achieved in the first half.

Dividend Sustainability

The Q2 dividend was ¥36.00 per share, representing a calculated first-half dividend payout ratio of 38.6% based on reported net income. This dividend-only payout ratio is below the 60% sustainability benchmark. The full-year dividend forecast is ¥76.00 per share, implying a prospective full-year payout ratio of approximately 50.8% against forecast EPS of ¥149.54. This suggests that the stated dividend policy remains supportable by forecast earnings. The interim dividend cash requirement is approximately ¥1.06bn, while first-half free cash flow was ¥0.57bn, yielding FCF coverage of 0.53x. Thus, dividends were not fully covered by first-half post-capex cash generation, even though balance-sheet liquidity readily bridges the gap. In addition, the company repurchased ¥8.99bn of shares during the period. Including the interim dividend, the first-half total return ratio was approximately 70%, calculated as dividends plus buybacks relative to first-half net income; this remains below the 80% sustainability benchmark but is considerably more demanding of cash than the dividend payout ratio alone suggests. Strong cash reserves and low leverage make the capital return program financially manageable in the near term. Longer-term sustainability will depend on conversion of receivables and inventory into operating cash flow, as reliance on cash balances would reduce financial flexibility.

Risk Assessment

Business risks include Working-capital risk is elevated: annualized DSO of 84 days and an annualized 123-day cash conversion cycle indicate slow cash realization from revenue and potential exposure to delayed customer collections., Chemical industrial-products sales revenue declined 2.1% YoY; a prolonged demand slowdown in this larger revenue segment would challenge the full-year 6.0% group sales-growth forecast., The machinery manufacturing and sales segment remains the core profit contributor but recorded a 0.7% YoY decline in segment profit; sustained margin pressure in this high-margin business would have a disproportionate group earnings impact., Industry-specific manufacturing risks include raw-material and energy-cost volatility, supply-chain disruption, customer capital-spending cyclicality, foreign-exchange movements, and product quality or delivery risks..

Financial risks include OCF/net income of 0.37x and OCF/EBITDA of 0.27x indicate weak first-half cash conversion despite positive accounting earnings., The ¥8.99bn share repurchase materially exceeded first-half free cash flow and contributed to a ¥1.19bn cash decrease; continued large buybacks would require cash-flow recovery or use of the existing cash reserve., Reported Q2 net income includes a net ¥3.43bn extraordinary gain, reducing the comparability and recurrence of bottom-line growth..

Key concerns include Prioritize receivable collection and normalization of the cash conversion cycle; the ¥1.49bn receivables outflow was the largest identified operating-cash-flow headwind., Monitor whether gross-margin expansion can offset SG&A growth, which was 5.5 percentage points faster than revenue growth., Assess second-half recurring profitability separately from first-half net income because the full-year guidance progress rate is elevated and first-half earnings include extraordinary items..

Investment Implications

Key takeaways include Operating profitability is robust: the 12.0% operating margin and 12.8% annualized ROE were achieved with conservative 1.30x financial leverage., Segment diversification supported earnings stability, with machinery delivering a 21.2% segment margin and chemical industrial-products improving its margin to 8.3%., The main analytical distinction is between resilient operating profit and weak cash realization, as first-half OCF reached only 37% of net income., The balance sheet provides substantial flexibility for investment, dividends, and buybacks, but capital returns should be assessed against free cash flow rather than accounting income alone., The first-half earnings run rate is ahead of full-year guidance, but extraordinary gains make the headline net-income outperformance less indicative of recurring earnings power..

Metrics to watch include Annualized DSO and the annualized cash conversion cycle, Operating cash flow to net income and operating cash flow to EBITDA, Chemical industrial-products sales recovery and segment margin, Machinery manufacturing and sales segment profit margin, SG&A growth relative to revenue growth, Second-half operating-income delivery relative to the ¥5.90bn full-year forecast, Scale and cadence of additional share repurchases relative to free cash flow.

Regarding relative positioning, 巴工業 combines above-average operating margins, a high-equity and highly liquid balance sheet, and a profitable machinery business with a lower-margin chemical-products sales operation. Its annualized 12.8% ROE is good, particularly because it is not leverage-driven. Relative positioning is tempered by a working-capital-intensive cash cycle and first-half cash conversion that lags reported earnings.